Evolent Health Inc (EVH) to Post Q1 2018 Earnings of ($0.02) Per Share, Leerink Swann Forecasts

Evolent Health Inc (NYSE:EVH) – Analysts at Leerink Swann issued their Q1 2018 earnings per share estimates for Evolent Health in a report released on Monday. Leerink Swann analyst D. Larsen expects that the technology company will earn ($0.02) per share for the quarter. Leerink Swann has a “Buy” rating and a $25.00 price target on the stock. Leerink Swann also issued estimates for Evolent Health’s Q2 2018 earnings at ($0.01) EPS, Q3 2018 earnings at ($0.01) EPS, Q4 2018 earnings at ($0.01) EPS, FY2018 earnings at ($0.05) EPS and FY2019 earnings at $0.17 EPS.

A number of other analysts also recently issued reports on EVH. J P Morgan Chase & Co reaffirmed a “buy” rating on shares of Evolent Health in a report on Friday, August 18th. Jefferies Group reaffirmed a “buy” rating and set a $28.00 price objective on shares of Evolent Health in a report on Wednesday, September 6th. KeyCorp initiated coverage on shares of Evolent Health in a report on Tuesday, September 19th. They set an “overweight” rating and a $23.00 price objective for the company. SunTrust Banks reaffirmed a “buy” rating and set a $30.00 price objective on shares of Evolent Health in a report on Wednesday, September 20th. Finally, Robert W. Baird reaffirmed an “outperform” rating and set a $25.00 price objective (down from $35.00) on shares of Evolent Health in a report on Tuesday, September 26th. They noted that the move was a valuation call. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and thirteen have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $28.00.

Evolent Health (NYSE EVH) traded down $0.10 during midday trading on Thursday, hitting $12.90. 1,177,000 shares of the stock were exchanged, compared to its average volume of 1,267,563. Evolent Health has a 52 week low of $10.30 and a 52 week high of $27.50. The company has a quick ratio of 3.34, a current ratio of 3.34 and a debt-to-equity ratio of 0.11.

Evolent Health (NYSE:EVH) last announced its quarterly earnings results on Thursday, November 2nd. The technology company reported ($0.04) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.08) by $0.04. Evolent Health had a negative net margin of 15.86% and a negative return on equity of 5.05%. The firm had revenue of $107.90 million during the quarter, compared to the consensus estimate of $104.49 million. During the same period last year, the firm earned ($0.26) EPS. The business’s quarterly revenue was up 79.2% compared to the same quarter last year.

A number of large investors have recently modified their holdings of EVH. FMR LLC raised its position in Evolent Health by 117.7% in the 2nd quarter. FMR LLC now owns 9,864,775 shares of the technology company’s stock worth $250,073,000 after purchasing an additional 5,333,252 shares during the period. JPMorgan Chase & Co. raised its position in Evolent Health by 37.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 7,465,019 shares of the technology company’s stock worth $136,236,000 after purchasing an additional 2,026,893 shares during the period. Vanguard Group Inc. raised its position in Evolent Health by 48.9% in the 2nd quarter. Vanguard Group Inc. now owns 3,769,869 shares of the technology company’s stock worth $95,566,000 after purchasing an additional 1,237,941 shares during the period. Eagle Asset Management Inc. purchased a new position in Evolent Health in the 2nd quarter worth $27,577,000. Finally, Kornitzer Capital Management Inc. KS purchased a new position in Evolent Health in the 3rd quarter worth $14,258,000. Institutional investors own 95.38% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece was first reported by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are viewing this piece on another website, it was copied illegally and reposted in violation of US and international copyright and trademark laws. The legal version of this piece can be read at https://www.truebluetribune.com/2017/12/15/evolent-health-inc-evh-to-post-q1-2018-earnings-of-0-02-per-share-leerink-swann-forecasts.html.

About Evolent Health

Evolent Health, Inc is engaged in healthcare delivery and payment. The Company supports health systems and physician organizations in their migration toward value-based care and population health management. The Company provides an end-to-end, technology-enabled services platform for providers. The Company’s platform, powered by its technology, processes and integrated services, enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to payment models that reward value-based payment models.

Earnings History and Estimates for Evolent Health (NYSE:EVH)

Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply